Results for 'Clinical trials'
MSL Talk: Tom Caravela, Brad Atkinson, Brian Wilson, Christina Wright
How and Why Medical Affairs Can Support Diversity in Clinical Trials
diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship
In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …
Aug 24th • 42 mins listen
MSL Talk: Tom Caravela, Khalil Ahmed
Evolving Role of MSL Field Support for Clinical Trials
Medical Science Liaisons, clinical trials, MSL involvement, Syneos Health, Khalil Ahmed
In this episode, Tom Caravela is joined by Khalil Ahmed to explore the integral role of Medical Science Liaisons (MSLs) in clinical trials. Khalil shares his background and discusses the significant impact MSLs have on site selection, recruitment, and training. The conversation delves into the …
Apr 4th • 34 mins listen
Cancer Buzz Podcast
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
Cancer Buzz Podcast
Improving Community Clinical Trial Participation
Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioriti…
Oct 13th • 6 mins listen
Cancer Buzz Podcast
Increasing Clinical Trial Access for Blood Cancers
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…
Jun 7th • 19 mins listen
Cancer Buzz Podcast
The Role of the Clinical Trials Navigator
Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment crit…
Aug 29th • 6 mins listen
Cancer Buzz Podcast
Clinical Trial Access in Rural Areas
Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …
Oct 16th • 24 mins listen
Cancer Buzz Podcast
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
ournal of Clinical Oncology (JCO) Podcast
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and the complexity of modernizing eligibility while maintaining trial integrity.
Mar 25th • 10 mins listen
Journal of Clinical Oncology (JCO) Podcast
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
Current clinical characteristics and demographics are not sufficient to capture aggressive disease in clinical trials of newly diagnosed DLBCL. Novel tools, such as measurement of tumor burden via ctDNA, are needed. By : Dr. Matthew Maurer.
Apr 10th • 7 mins listen
Journal of Clinical Oncology (JCO) Podcast
Improving Transparency in Phase 1 Clinical Trials
Dr. Shannon Westin and her guests, Dr. Paul Frankel, Dr. Judith Karp, and Dr. Robert Maki discuss how to better inform patients of the risks involved in phase 1 clinical trials.
Feb 9th • 29 mins listen
Journal of Clinical Oncology (JCO) Podcast
Barriers to Clinical Trial Participation for Transgender People
What factors could be excluding transgender people from oncology clinical trials, and what can we do to make them more inclusive? Dr. Westin discusses this important issue with her guests, Dr. Ash Alpert and Dr. Lola Fashoyin-Aje.
Apr 25th • 26 mins listen
Asco Daily News Podcast
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
On today's episode, we will be discussing the promise of artificial intelligence to improve patient recruitment in clinical trials and advanced clinical research. Joining me for this discussion is Dr. Arturo Loaiza-Bonilla, the medical director of oncology research at Capital Health in Philad…
Aug 15th • 19 mins listen
The Oncology Nursing Podcast
The Practical Side of Clinical Trials
ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS’s Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, han…
Sep 18th • 39 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen
The Oncology Nursing Podcast
Diversity in Cancer Clinical Trials
“I think it’s important to ensure that you consider each person uniquely. Because no matter how much I know or the nurse knows about the population, everybody is a little bit different. It’s really important to personalize every approach and ask them what they know and meet them …
May 29th • 27 mins listen
Cancer Buzz Podcast
Advanced Practitioners’ Role in Research
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so. Hear how APs can leverage their deep role in the day-to-day cancer care decisions to improve diversit…
Jul 13th • 6 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen
The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
CDER, FDA, Nurses, biomarker, immunomodulatory
Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…
Mar 30th • 53 mins listen